Celltrion
068270.KS
#741
Rank
A$48.66 B
Marketcap
A$222.42
Share price
1.88%
Change (1 day)
12.57%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.83. In 2023 the company made an earnings per share (EPS) of A$4.14 a decrease over its 2022 EPS that were of A$4.23.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$2.88
2023A$4.14-2.08%
2022A$4.23-11.72%
2021A$4.792.03%
2020A$4.6982.8%
2019A$2.5718.31%
2018A$2.17-36.33%
2017A$3.41161.25%
2016A$1.302.86%
2015A$1.2717.84%
2014A$1.085.87%
2013A$1.02-70.85%
2012A$3.49134.09%
2011A$1.4943.59%
2010A$1.0474.49%
2009A$0.59317.8%
2008A$0.14-71.7%
2007A$0.50